SCHEMBL7670538

SCHEMBL7670538

COc1ccc(Sc2ccnc(Nc3ccc(OCCN(C)C)cc3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
RAB9A P51151 1/20 0.49
CDK4 P11802 2/20 0.48
CDK2 P24941 1/20 0.48
PLK4 O00444 8/20 0.47
EGFR P00533 2/20 0.46
ERBB3 P21860 2/20 0.46
LCK P06239 1/20 0.46
SRC P12931 1/20 0.46
KDR P35968 1/20 0.46
MAPK14 Q16539 1/20 0.46
PIK3CA P42336 1/20 0.46
PIK3CB P42338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13169478 0.82 PLK4 (0.70) IKBKBMEN1KMT2ANPC1ALDH1A1
SCHEMBL3701102 0.82 PLK4 (0.70) IKBKBMEN1KMT2ANPC1ALDH1A1
SCHEMBL7476936 0.75 IKBKB (0.72) IKBKBMEN1KMT2ACDK4PIK3CA
SCHEMBL13169413 0.74 PLK4 (0.79) PLK4
SCHEMBL3693031 0.74 TGM2 (0.56) MEN1KMT2ANPC1ALDH1A1LMNA
SCHEMBL13169463 0.74 TGM2 (0.56) MEN1KMT2ANPC1ALDH1A1LMNA
SCHEMBL3693261 0.74 MEN1 (0.47) MEN1KMT2ANPC1ALDH1A1LMNA
SCHEMBL13169475 0.74 JAK1 (0.47) MEN1KMT2ANPC1ALDH1A1LMNA
SCHEMBL13169420 0.74 JAK1 (0.47) MEN1KMT2ANPC1ALDH1A1LMNA
SCHEMBL13169430 0.74 PLK4 (0.76) IKBKBPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6337335-B1 ENZYME INHIBITORS FOR AUTOIMMUNE DISEASES, TRANSPLANT REJECTION, GRANT VERSUS HOST DISEASE, HYPERPROLIFERATIVE DISORDERS AND DISEASES IN WHICH CELLS RECEIVE PRO-INFLAMMATORY SIGNALS. CELLTECH THERAPEUTICS LIMITED (GB) 2002-01-08 US disclosed
US-6048866-A Substituted 2-anilinopryimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS, LIMITED (GB) 2000-04-11 US disclosed